See also this year's filing and all EDGAR filings for this company.
PDF Report 0001069530_2026_Filana_Therapeutics_INC.pdf
Logs
Graph
Absolute values for 0001069530, Filana Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 97,709,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 20,646,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 43,834,000 |
| 5 | LiabilitiesNoncurrent | 118,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 68,678,533 |
| 9 | ResearchAndDevelopmentExpense | 30,720,302 |
| 10 | remainder_Expenses | -27,394,443 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,994,318 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 118,355,000 |
| 1 | Liabilities | 43,952,000 |
| 2 | Expenses | 72,004,392 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 74,403,000 |
| 5 | NetIncome | -68,010,074 |
| 6 | ComprehensiveNetIncome | -68,010,074 |
| 7 | BaseVar | 119,152,855 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.16 |
| 9 | EconomicCapitalRatio | 2.43 |
Edgar->Model Mapping
Feature Distribution
Change over Time
